HomeLarge Type Edition
HOME ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
PubMed
Right arrow PubMed Citation
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:622-626 (2005)
© 2005 The Gerontological Society of America

Psychotropic Medications and Risk for Falls Among Community-Dwelling Frail Older People: An Observational Study

Francesco Landi1,, Graziano Onder1,2, Matteo Cesari1,2, Christian Barillaro1, Andrea Russo1, Roberto Bernabei1 and on Behalf of the Silver Network Home Care Study Group

1 Department of Gerontology-Geriatrics, Catholic University of Sacred Heart, Rome, Italy.
2 Sticht Center on Aging, Wake Forest University-Baptist Medical Center, Winston Salem, North Carolina.

Address correspondence to Dr. Francesco Landi, Istituto di Medicina Interna e Geriatria, Centro Medicina dell'Invecchiamento (C.E.M.I.), Universitá Cattolica del Sacro Cuore, Largo Agostino Gemelli, 8, 00168 Rome, Italy. E-mail: francesco_landi{at}rm.unicatt.it

Background. Injuries due to falls are one of the most important public health concerns for all ages, but especially for frail elderly people. Although a small number of falls have a single cause, the majority have many different causes resulting from the interactions between intrinsic or extrinsic risk factors.

Methods. We conducted an observational study on data from a large population of community-dwelling elderly people to tests the hypothesis that the current use of different classes of psychotropic medications, including antipsychotic agents, benzodiazepines, nonbenzodiazepine sedative-hypnotics, and antidepressants, increases the risk for falls. We analyzed data from a large collaborative observational study group, the Italian Silver Network Home Care project, that collected data on patients admitted to home care programs (n = 2854).

Results. After adjusting for all potential confounders, users of any psychotropic drugs had an increased risk of fall of nearly 47% (adjusted odds ratio [OR], 1.47; 95% confidence interval [CI], 1.24–1.74). Similarly, compared with nonusers, users of atypical antipsychotic drugs also had an increased risk of falling at least once (OR, 1.45; 95% CI, 1.00–2.11). Among benzodiazepine users, patients taking agents with long elimination half-life (OR, 1.45; 95% CI, 1.00–2.19) and patients taking benzodiazepines with short elimination half-life (OR, 1.32; 95% CI, 1.02–1.72) had an increased risk of falls. Patients taking antidepressants did not show a higher risk of falling compared to nonusers (OR, 0.92; 95% CI, 0.83–1.41).

Conclusions. Our data suggest that, among psychotropic medications, antipsychotic agents and benzodiazepines are associated with an increased risk of falls. Our findings do not support the hypothesis that preferential prescribing of short-acting benzodiazepines instead of long-acting agents or atypical antipsychotic medications instead of typical agents will substantially decrease fall risk associated with the use of these classes of drugs.




This article has been cited by other articles:


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
B. Mezuk, W. W. Eaton, S. H. Golden, G. Wand, and H. B. Lee
Depression, Antidepressants, and Bone Mineral Density in a Population-Based Cohort
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2008; 63(12): 1410 - 1415.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. L. Stone, S. Ancoli-Israel, T. Blackwell, K. E. Ensrud, J. A. Cauley, S. Redline, T. A. Hillier, J. Schneider, D. Claman, and S. R. Cummings
Actigraphy-Measured Sleep Characteristics and Risk of Falls in Older Women
Arch Intern Med, September 8, 2008; 168(16): 1768 - 1775.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
R. Bernabei, F. Landi, G. Onder, R. Liperoti, and G. Gambassi
Multidimensional Geriatric Assessment: Back to the Future Second and Third Generation Assessment Instruments: The Birth of Standardization in Geriatric Care
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2008; 63(3): 308 - 313.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
K. A. Swanson and R. M. Carnahan
Dementia and Comorbidities: An Overview of Diagnosis and Management
Journal of Pharmacy Practice, August 1, 2007; 20(4): 296 - 317.
[Abstract] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
R. D. Nebes, B. G. Pollock, E. M. Halligan, M. A. Kirshner, and P. R. Houck
Serum Anticholinergic Activity and Motor Performance in Elderly Persons
J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2007; 62(1): 83 - 85.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. W. Johnson, P. E. Suess, and R. R. Griffiths
Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
Arch Gen Psychiatry, October 1, 2006; 63(10): 1149 - 1157.
[Abstract] [Full Text] [PDF]


Home page
Inj. Prev.Home page
H M Tiesman, C Peek-Asa, P Whitten, N L Sprince, A Stromquist, and C Zwerling
Depressive symptoms as a risk factor for unintentional injury: a cohort study in a rural county.
Inj. Prev., June 1, 2006; 12(3): 172 - 177.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
S. A. Quandt, J. M. Stafford, R. A. Bell, S. L. Smith, B. M. Snively, and T. A. Arcury
Predictors of falls in a multiethnic population of older rural adults with diabetes.
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2006; 61(4): 394 - 398.
[Abstract] [Full Text] [PDF]




HOME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The Gerontological Society of America.